Glycerol can alleviate the symptoms of ketosis when delivered as an oral drench. The addition of glycerol to the diet would eliminate the need for restraining cows for drenching yet deliver a glucogenic substrate, alleviate the fatty liver-ketosis complex, and improve lactational performance. For this study, 21 multiparous and 9 primiparous Holstein cows blocked by parity and expected calving date were used in a randomized block design to evaluate the effects of feeding glycerol from 14 d prepartum to 21 d in milk (DIM). Treatments (kg/d dry matter basis) were 0.86 of cornstarch (control), 0.43 cornstarch + 0.43 glycerol (LG), or 0.86 glycerol (HG), topdressed and hand-mixed into the upper one-third of the daily ration. All cows were fed a common diet from 22 to 70 DIM. Prepartum dry matter intake (DMI) was greater for cows fed the control diet compared with LG or HG (13.3, 10.8, and 11.3 +/- 0.50 kg/d, respectively). Prepartum plasma glucose, insulin, beta-hydroxybutyrate, nonesterified fatty acids, and ruminal profiles were not affected by treatments. Rumen fluid collected postpartum from cows fed LG and HG had greater total volatile fatty acids, greater molar proportions of propionate, and a decreased ratio of acetate to propionate. Furthermore, concentrations of butyrate tended to be greater in rumens of cows fed LG and HG. Postpartum concentrations of glucose in plasma were greatest for cows fed the control diet relative to LG and HG (66.0 vs. 63.1 and 58.4 mg/dL, respectively) and decreased sharply at 21 DIM, after treatments ended, for cows fed HG (diet x day interaction). Body weight and condition loss, plasma nonesterified fatty acids, and liver lipids during the first 21 DIM were similar among treatments. Postpartum DMI was not affected by treatments; however, a tendency was observed for a diet x day interaction for body weight, as cows fed LG gained more body weight from 21 to 70 DIM relative to cows fed HG. Yield of energy-corrected milk during the first 70 DIM tended to be greatest for cows fed the control diet. The LG and HG diets decreased urea nitrogen concentrations in milk relative to controls. Based upon prepartum DMI and concentrations of glucose and beta-hydroxybutyrate in blood postpartum, feeding glycerol to dairy cows at the levels used in this experiment increased indicators used to gauge the degree of ketosis in dairy cattle.
Trials were conducted to test the efficacy of a calcium propionate paste as an aid to prevent milk fever and to improve the health of dairy cows. Each calcium propionate treatment tube supplied 37 g of calcium. In trials involving Holstein herds and a Jersey herd, two (trials 1 and 2) or three (trial 3) calcium propionate tubes were given at calving and again at 12 h after calving. For the Jersey herd, calcium propionate treatment (two tubes) reduced the incidence of milk fever from 50% in control cows to 29% in treated cows. Plasma obtained 24 h after calving from treated cows had higher calcium, lower NEFA, and lower beta-hydroxybutyrate concentrations than did plasma from control cows. No other benefits of calcium propionate treatment were significant for health or for productivity of the cows. Calcium propionate treatment had no significant effects on blood calcium, NEFA, or beta-hydroxybutyrate in the Holstein herds studied. However, calcium propionate did reduce the number of cows with subclinical hypocalcemia (< or = 7.5 mg/dl of plasma calcium) at 24 h after calving in both trials involving Holstein cows. Calcium propionate treatment was beneficial in reducing subclinical hypocalcemia in all trials and reduced the incidence of milk fever in a herd having a problem with milk fever.
Data from multiparous Holstein cows (n = 43) were used to determine whether supplementation of anions to low-potassium (K) prepartum diets would improve periparturient energy and macromineral status and affect performance during the postpartum period. Beginning 21 d before expected parturition, cows were fed a control diet (1.29% K; +10 mEq/100 g; n = 21) or a low dietary cation-anion difference (DCAD) diet (1.29% K; -15 mEq/100 g; n = 22) with anions provided through a combination of sulfate from calcium sulfate dihydrate (0.40% S total ration) and chloride (1.17% Cl total ration) from SoyChlor 16-7 (West Central, Ralston, IA). All cows were fed the same postpartum diet from parturition through 63 d postpartum. Feeding anions decreased overall urine pH (8.17 vs. 6.70) during the prepartum period. Overall, peripartum concentrations of plasma Ca, P, and Mg were similar between treatments; however, concentrations of plasma Ca tended to be increased during the first 24 h postcalving in cows fed the low DCAD diet. Overall, concentrations of plasma P tended to be increased by feeding the anionic diet prepartum; this effect was more pronounced during the immediate peripartal period. Anionic supplementation did not affect incidence of clinical (<5 mg/dL) and subclinical (5 to 8 mg/dL) hypocalcemia, clinical hypophosphatemia (<2 mg/dL), or clinical (<1.1 mg/dL) and subclinical (1.1 to 1.8 mg/dL) hypomagnesemia. Nevertheless, subclinical hypophosphatemia (2 to 4 mg/dL) tended to be decreased at 16 h postcalving and was decreased at d 2 postpartum for cows fed the anionic diet prepartum. Anion supplementation decreased prepartum dry matter intake (15.6 vs. 14.4 kg/d), but did not affect postpartum dry matter intake (22.4 vs. 23.0 kg/d), milk yield (46.5 vs. 46.1 kg/d), or content and yield of milk fat and true protein. Plasma concentrations of energy-related metabolites (glucose, nonesterified fatty acids, beta-hydroxybutyrate) were similar for both groups during the prepartum and postpartum periods. Glucose rate of appearance was determined by continuous infusion of 6,6-dideuterated glucose in a subset of cows between 6 and 10 d prepartum (control, n = 12; low DCAD, n = 9) and 7 and 10 d postpartum (control, n = 9; low DCAD, n = 8) periods. Glucose rate of appearance was not affected by treatment during the prepartum or postpartum periods. Overall, anion supplementation of low K diets improved P status during the early postpartum period, but did not affect aspects of energy metabolism or periparturient performance.
Four lactating dairy cows equipped with ruminal and duodenal cannulas were used to determine the impact of different methods of treating soybean meal (SBM) on the ruminal degradability and intestinal digestibility of crude protein and AA. Solvent-extracted SBM (SE), expeller SBM (EP), lignosulfonate SBM (LS), and heat and soyhulls SBM (HS) were incubated in the rumen in nylon bags for 48, 24, 16, 8, 4, 2, and 0 h according to National Research Council (2001) guidelines. Additional samples of each SBM product were also incubated for 16 h in the rumen; the residues from these bags were transferred to mobile bags, soaked in pepsin HCl, and then used for determination of intestinal digestibility in situ or in vitro. Treatment of SBM (EP, LS, HS) protected the crude protein and AA from ruminal degradation, increasing rumen undegradable protein from 42% in SE to 68% in EP. Kinetic analysis of crude protein and AA degradation in the rumen revealed that, compared with LS and HS, EP exhibited slower rates of degradation but a shorter lag phase and a higher proportion of soluble protein. For all SBM products, the pattern of ruminal degradation, at 16 h of incubation, was characterized by extensive degradation of Lys and His, whereas Met and the branched-chain AA were degraded to the least extent. Estimates of intestinal digestibility of AA and crude protein were lower when measured in vitro than in situ; the magnitude of the difference between the 2 methods was greater (25%) with treated SBM products than with SE (10%). The availability of essential and nonessential AA was consistently greater (30%) with treated SBM than with SE. Among the treated SBM products, 4 essential AA (Ile, Leu, Phe, and Val) showed differences in availability, with values consistently lower for HS than for LS. This study showed that, based on in situ measures, heat and chemical treatment of SBM enhanced AA availability, and that compared with HS, EP and LS had a higher potential to enhance the AA supply to the small intestine of high-producing dairy cows.
This study compared the effects of two levels of crude protein (CP) fed during late gestation on the performance, blood metabolites, and ovarian activity of Holstein cows. One-hundred and six cows (42 primigravid and 64 multiparous) 32 d before calving were divided into two groups and fed diets containing moderate (12.7% CP, 36% rumen undegradable protein, (RUP) or high (14.7% CP, 40% RUP) protein. Higher prepartum CP diet increased milk production during the first 120 d in milk (DIM), but most of that effect was detected for the primigravid cows. Primigravid cows fed the prepartum diet higher in protein produced 2.0 kg/d more milk and 3.1 kg/d more 3.5% fat-corrected milk (FCM) during early lactation. Yields of milk fat and protein in early lactation were also increased by the high prepartum CP diet fed to primigravid cows. During the complete lactation, the response to prepartum dietary protein differed between primigravid and multiparous cows. Yields of milk, 3.5% FCM, and milk fat and protein were not affected by the prepartum diet for primigravid cows, but decreased for multiparous cows fed the high protein diet. However, primigravid cows fed the high prepartum protein diet had a higher 305-d mature equivalent milk yield. Colostrum composition, blood metabolites, ovarian activity, and disease incidence were not influenced by prepartum protein. Data from this study suggest that the current prepartum protein recommendation seems to be adequate for multiparous cows, but late-gestation primigravid cows might benefit from diets with a CP content above 12.7%.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.